Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces...
Antimicrobial
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces...
The Longevity Center Introduces Ozone Shots as New Option for Prostate Health
The newly offered, targeted ozone injections are a minimally invasive therapy with potential benefits for prostate tissue and function GREENVILLE,...
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months...
InsightRX Surpasses 1,000 Hospital Deployments as the Most Widely Used AI Precision Dosing Software
SAN FRANCISCO, Dec. 4, 2025 /PRNewswire/ -- InsightRX today announced the company's AI precision dosing software is now deployed across...
Kane Biotech Announces Third Quarter 2025 Financial Results
WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced...
Kane Biotech Announces New Private Placement Offering
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Nov. 27, 2025 (GLOBE...
Using Antibiotics Wisely. Making Them Responsibly.
NORTHAMPTON, MA / ACCESS Newswire / November 25, 2025 / You wake up with a sore throat and a fever....
MicrobiotiX and West Africa Centre for Innovative Research and Care in Ghana Sign MoU to Advance Clinical Development of Bacteriophage Therapeutics and Combat AMR·MDR in Africa
SEOUL, South Korea, Nov. 20, 2025 (GLOBE NEWSWIRE) -- MicrobiotiX, a company specializing in the development of novel bacteriophage therapeutics,...
Bitscopic appoints Kelly Echevarria, Pharm.D., BCIDP to advance VA antimicrobial stewardship with PraediAlert
After 25+ years in VA infectious diseases and national leadership, Echevarria joins Bitscopic to help VAMCs strengthen antimicrobial stewardship programs (ASP)...
Omnix Medical and Prevail Partners, LLC Announce Strategic and Financial Partnership
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / November 6, 2025 / Omnix Medical Ltd., P.C. ("Omnix Medical") and Prevail Partners, LLC...
Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients
The milestone underscores Arkstone's leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding...
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
Korea’s First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in...
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
Korea’s First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in...
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
Korea’s First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in...
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
NASP data highlight reduction in disease burden among people living with uncontrolled gout Gamifant (emapalumab) data showed response rates in...
BioLab Holdings, Inc. Announces Investment in Cold Atmospheric Plasma Technology
Partnership Will Advance Portable Antimicrobial Solutions for Wound Care and Dermatology PHOENIX, Oct. 24, 2025 /PRNewswire/ -- BioLab Holdings, Inc.,...
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating
Vancouver, British Columbia--(Newsfile Corp. - October 22, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company"...
VTT identifies new plant-based anti-inflammatory and anti-ageing ingredients for sustainable cosmetics
ESPOO, Finland, Oct. 15, 2025 /PRNewswire/ -- In a landmark collaborative project, scientists at the VTT Technical Research Centre of...